AU2022903962A0 - Targeted combination cancer therapy - Google Patents

Targeted combination cancer therapy

Info

Publication number
AU2022903962A0
AU2022903962A0 AU2022903962A AU2022903962A AU2022903962A0 AU 2022903962 A0 AU2022903962 A0 AU 2022903962A0 AU 2022903962 A AU2022903962 A AU 2022903962A AU 2022903962 A AU2022903962 A AU 2022903962A AU 2022903962 A0 AU2022903962 A0 AU 2022903962A0
Authority
AU
Australia
Prior art keywords
cancer therapy
combination cancer
targeted combination
targeted
therapy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2022903962A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Clarity Pharmaceuticals Ltd
Original Assignee
Clarity Pharmaceuticals Ltd
Filing date
Publication date
Application filed by Clarity Pharmaceuticals Ltd filed Critical Clarity Pharmaceuticals Ltd
Publication of AU2022903962A0 publication Critical patent/AU2022903962A0/en
Pending legal-status Critical Current

Links

AU2022903962A 2022-12-22 Targeted combination cancer therapy Pending AU2022903962A0 (en)

Publications (1)

Publication Number Publication Date
AU2022903962A0 true AU2022903962A0 (en) 2023-01-19

Family

ID=

Similar Documents

Publication Publication Date Title
EP4010081A4 (en) Combination therapy for treatment of cancer
EP4055033A4 (en) Combination therapy to treat brain cancer
EP3962524A4 (en) Cancer treatment
IL307964A (en) Combination therapy for cancer treatment
GB202301902D0 (en) Combination therapy for cancer
EP3849544A4 (en) Combination therapy for the treatment of prostate cancer
AU2022903962A0 (en) Targeted combination cancer therapy
EP4087563A4 (en) Combination cancer therapy using chk inhibitor
EP3955943A4 (en) Gmci and ddri combination therapy for treating cancer
EP3958980A4 (en) Targeted novel triazolothiadiazine derivatives for the treatment of lung cancer
AU2023901714A0 (en) Combination cancer therapy
EP3999092A4 (en) Combination cancer therapy agents and methods
EP3981473A4 (en) Therapeutic agent for cancer
AU2023903316A0 (en) Novel cancer therapy
AU2022903054A0 (en) Novel cancer therapy
AU2023901713A0 (en) Targeted dual administration cancer therapy
GB202318158D0 (en) Cancer therapy
GB202302018D0 (en) Cancer therapy
GB202218395D0 (en) Cancer therapy
GB202212918D0 (en) Cancer therapy
AU2023902987A0 (en) Combination therapy
AU2023901510A0 (en) Combination Therapy
AU2023900354A0 (en) Combination therapy
AU2022903061A0 (en) Combination Therapy
AU2022901582A0 (en) Combination therapy